Encompass Health Financials
EHC Stock | USD 98.41 2.84 2.97% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Net Profit Margin | 0.0647 | 0.066 |
|
| |||||
Return On Assets | 0.0324 | 0.0519 |
|
| |||||
Current Ratio | 2.65 | 1.47 |
|
|
Investors should never underestimate Encompass Health's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Encompass Health's cash flow, debt, and profitability to make informed and accurate decisions about investing in Encompass Health Corp.
Cash And Equivalents |
|
Encompass | Select Account or Indicator |
Understanding current and past Encompass Health Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Encompass Health's financial statements are interrelated, with each one affecting the others. For example, an increase in Encompass Health's assets may result in an increase in income on the income statement.
Please note, the presentation of Encompass Health's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Encompass Health's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Encompass Health's management manipulating its earnings.
Encompass Health Stock Summary
Encompass Health competes with Pennant, Ensign, InnovAge Holding, ModivCare, and Acadia Healthcare. Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama. Encompass Health operates under Medical Care Facilities classification in the United States and is traded on New York Stock Exchange. It employs 34900 people.Specialization | Health Care, Health Care Equipment & Services |
Instrument | USA Stock View All |
Exchange | New York Stock Exchange |
ISIN | US29261A1007 |
CUSIP | 29261A100 421924309 421924101 |
Location | Alabama; U.S.A |
Business Address | 9001 Liberty Parkway, |
Sector | Health Care Providers & Services |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.encompasshealth.com |
Phone | 205 967 7116 |
Currency | USD - US Dollar |
Encompass Health Key Financial Ratios
Return On Equity | 0.23 | ||||
Profit Margin | 0.08 % | ||||
Operating Margin | 0.15 % | ||||
Price To Sales | 1.85 X | ||||
Revenue | 4.8 B |
Encompass Health Key Balance Sheet Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Total Assets | 6.4B | 6.9B | 5.6B | 6.1B | 7.0B | 3.8B | |
Other Current Liab | 474.4M | 510.1M | 366.6M | 437.5M | 503.1M | 380.4M | |
Net Debt | 3.3B | 3.5B | 3.0B | 2.9B | 3.3B | 2.1B | |
Retained Earnings | (242.3M) | 141.8M | 115.7M | 406.5M | 365.9M | 384.1M | |
Cash | 224M | 54.8M | 21.8M | 69.1M | 79.5M | 111.7M | |
Net Receivables | 572.8M | 502.1M | 536.8M | 611.6M | 703.3M | 436.2M | |
Inventory | 65.4M | 65.1M | 31.6M | 72.7M | 83.6M | 77.7M | |
Other Current Assets | 151.8M | 369.9M | 170.6M | 161.1M | 185.3M | 168.3M | |
Total Liab | 4.4B | 4.5B | 3.8B | 3.8B | 4.4B | 2.9B | |
Total Current Assets | 948.6M | 921.4M | 717.2M | 841.8M | 968.1M | 734.0M | |
Short Term Debt | 127.9M | 104.7M | 76.4M | 48.9M | 56.2M | 59.2M | |
Intangible Assets | 431.3M | 417.5M | 282.3M | 278.2M | 319.9M | 222.5M | |
Accounts Payable | 115M | 134M | 132.9M | 170M | 195.5M | 205.3M | |
Other Liab | 159.9M | 266.8M | 259.9M | 257.2M | 231.5M | 172.7M | |
Other Assets | 542M | 254.5M | 222.1M | 1.0 | 0.9 | 0.86 | |
Long Term Debt | 3.3B | 3.2B | 2.7B | 2.7B | 2.4B | 2.0B | |
Treasury Stock | (427.9M) | (492.3M) | (497.4M) | (521.2M) | (469.1M) | (492.5M) | |
Good Will | 2.3B | 2.4B | 1.3B | 1.3B | 1.5B | 1.3B | |
Net Tangible Assets | (1.2B) | (699.1M) | (934.1M) | (235.2M) | (211.7M) | (222.3M) | |
Warrants | 261.7M | 239.6M | 31.6M | 42.2M | 38.0M | 36.1M |
Encompass Health Key Income Statement Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Interest Expense | 184.2M | 164.6M | 175.7M | 143.5M | 165.0M | 93.8M | |
Total Revenue | 4.6B | 5.1B | 4.3B | 4.8B | 5.5B | 2.8B | |
Gross Profit | 4.4B | 4.9B | 4.1B | 933.5M | 1.1B | 2.1B | |
Operating Income | 661.9M | 822.8M | 627.9M | 731.8M | 841.6M | 534.2M | |
Ebit | 572.2M | 659.4M | 630.2M | 750.7M | 863.3M | 605.7M | |
Ebitda | 815.2M | 879M | 873.8M | 1.0B | 1.2B | 762.9M | |
Cost Of Revenue | 200.5M | 209.3M | 202.1M | 3.9B | 3.5B | 3.7B | |
Income Before Tax | 472.6M | 657.2M | 450.8M | 607.2M | 698.3M | 733.2M | |
Net Income | 284.2M | 412.2M | 271M | 352M | 404.8M | 425.0M | |
Income Tax Expense | 103.8M | 139.6M | 100.1M | 132.2M | 152.0M | 159.6M | |
Minority Interest | (84.6M) | (105M) | (94.9M) | (107.6M) | (96.8M) | (92.0M) | |
Tax Provision | 103.8M | 139.6M | 100.1M | 126.9M | 114.2M | 104.1M | |
Interest Income | 153M | 180.7M | 160.6M | 172.8M | 198.7M | 171.2M | |
Extraordinary Items | 1.1M | (600K) | 89.3M | 13.9M | 16.0M | 14.0M | |
Net Interest Income | (184.2M) | (164.6M) | (175.7M) | (146.1M) | (131.5M) | (138.1M) |
Encompass Health Key Cash Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Change In Cash | 151.3M | (190.6M) | (66.9M) | 50.8M | 45.7M | 31.1M | |
Free Cash Flow | 296.5M | 164.6M | 121.7M | 267.7M | 307.9M | 174.4M | |
Depreciation | 243M | 256.6M | 243.6M | 273.9M | 315.0M | 176.0M | |
Other Non Cash Items | 18.3M | (1M) | 69.6M | 110.5M | 99.5M | 133.3M | |
Capital Expenditures | 408.2M | 551.2M | 584.1M | 583.1M | 670.6M | 704.1M | |
Net Income | 368.8M | 517.6M | 365.9M | 361.6M | 415.8M | 436.6M | |
End Period Cash Flow | 310.9M | 120.3M | 53.4M | 104.2M | 93.8M | 115.6M | |
Dividends Paid | 111.9M | 112.4M | 99M | 60.4M | 54.4M | 51.6M | |
Net Borrowings | 454.5M | 208.9M | (66.3M) | (498.2M) | (448.4M) | (426.0M) | |
Change To Netincome | 189.5M | 335.9M | 157.2M | 211.9M | 243.7M | 171.7M | |
Investments | (407.5M) | (666.3M) | (627M) | (601.1M) | (541.0M) | (513.9M) |
Encompass Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Encompass Health's current stock value. Our valuation model uses many indicators to compare Encompass Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Encompass Health competition to find correlations between indicators driving Encompass Health's intrinsic value. More Info.Encompass Health Corp is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.37 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Encompass Health Corp is roughly 2.74 . At present, Encompass Health's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Encompass Health's earnings, one of the primary drivers of an investment's value.Encompass Health Corp Systematic Risk
Encompass Health's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Encompass Health volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Beta measures systematic risk based on how returns on Encompass Health Corp correlated with the market. If Beta is less than 0 Encompass Health generally moves in the opposite direction as compared to the market. If Encompass Health Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Encompass Health Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Encompass Health is generally in the same direction as the market. If Beta > 1 Encompass Health moves generally in the same direction as, but more than the movement of the benchmark.
Encompass Health Thematic Clasifications
Encompass Health Corp is part of Healthcare investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Healthcare industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
This theme covers USA Equities from Healthcare industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
Healthcare | View |
Today, most investors in Encompass Health Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Encompass Health's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Encompass Health growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Encompass Health January 30, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Encompass Health help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Encompass Health Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Encompass Health Corp based on widely used predictive technical indicators. In general, we focus on analyzing Encompass Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Encompass Health's daily price indicators and compare them against related drivers.
Downside Deviation | 1.17 | |||
Information Ratio | (0.05) | |||
Maximum Drawdown | 10.3 | |||
Value At Risk | (1.93) | |||
Potential Upside | 1.66 |
Complementary Tools for Encompass Stock analysis
When running Encompass Health's price analysis, check to measure Encompass Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Encompass Health is operating at the current time. Most of Encompass Health's value examination focuses on studying past and present price action to predict the probability of Encompass Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Encompass Health's price. Additionally, you may evaluate how the addition of Encompass Health to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Commodity Directory Find actively traded commodities issued by global exchanges |